Testing confirmed a diagnosis of AHA, with FVIII activity <0.01 IU/mL (reference: 0.50–2.00 IU/mL) and a FVIII inhibitor level of 28.8 BU (reference: <0.6 BU). Here, F8 is linked to autoimmune hemolytic anemia.